Effect of Menopausal Hormone Therapy on Immune System Parameters

Phase 1 Completed 40 enrolled Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare

RandomizedParallel-groupSingle-blindPrevention

Summary

The objective of the study is to evaluate the effect of menopausal hormone therapy on the parameters of the immune system. To do this, patients took blood to assess the immune status before the start of therapy and after 3 months. An additional task is to assess the content of blood sex hormones before the start of therapy and after 3 months.

Timeline

Start: 2021-12-01
Primary completion: 2023-03-01
Completion: 2023-03-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dydrogesterone	Other / unclassified	5 mg	Oral
Subject	Dydrogesterone	Other / unclassified	10 mg	Oral
Subject	Estradiol	Other / unclassified	1 mg	Oral
Subject	Estradiol	Other / unclassified	1.5 mg	Oral
Subject	Progesterone	Other / unclassified	100 mg	Other
Subject	Progesterone	Other / unclassified	200 mg	Other

Indications

No indication recorded.